These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 21452105)

  • 1. [Mabs and Co. in oncological treatment].
    Bruhn C
    Dtsch Med Wochenschr; 2011 Apr; 136 Suppl 1():S9-12. PubMed ID: 21452105
    [No Abstract]   [Full Text] [Related]  

  • 2. [New oncological drugs].
    Pyrhönen S
    Duodecim; 2000; 116(24):2841-52. PubMed ID: 12077890
    [No Abstract]   [Full Text] [Related]  

  • 3. [Individualisation and "orphanization" in oncology].
    Schenk M
    Dtsch Med Wochenschr; 2011 Apr; 136 Suppl 1():S27-30. PubMed ID: 21452104
    [No Abstract]   [Full Text] [Related]  

  • 4. Development trends for monoclonal antibody cancer therapeutics.
    Reichert JM; Valge-Archer VE
    Nat Rev Drug Discov; 2007 May; 6(5):349-56. PubMed ID: 17431406
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Two new indications for rituximab.
    Kahl BS
    Clin Adv Hematol Oncol; 2006 Dec; 4(12):901, 934. PubMed ID: 17235273
    [No Abstract]   [Full Text] [Related]  

  • 6. A magic bullet for cancer--how near and how far?
    Schnipper LE; Strom TB
    N Engl J Med; 2001 Jul; 345(4):283-4. PubMed ID: 11474668
    [No Abstract]   [Full Text] [Related]  

  • 7. Antibody-directed enzyme prodrug therapy.
    Connors TA
    Cancer Cells; 1990 Feb; 2(2):56-7. PubMed ID: 2397145
    [No Abstract]   [Full Text] [Related]  

  • 8. Antibody-drug conjugates for cancer: poised to deliver?
    Hughes B
    Nat Rev Drug Discov; 2010 Sep; 9(9):665-7. PubMed ID: 20811367
    [No Abstract]   [Full Text] [Related]  

  • 9. [Targeted drugs a chance for a better cure].
    Bergh J; Jonsson B
    Lakartidningen; 2010 Apr 21-27; 107(16):1071-4. PubMed ID: 20476704
    [No Abstract]   [Full Text] [Related]  

  • 10. Introduction: targeting different pathways to prevent tumor cell development.
    Kantarjian HM
    Semin Oncol; 2009 Apr; 36(2 Suppl 1):S1-5. PubMed ID: 19393830
    [No Abstract]   [Full Text] [Related]  

  • 11. Drug-conjugated monoclonal antibodies for the treatment of cancer.
    Lambert JM
    Curr Opin Pharmacol; 2005 Oct; 5(5):543-9. PubMed ID: 16087399
    [TBL] [Abstract][Full Text] [Related]  

  • 12. EGFR targeting therapies: monoclonal antibodies versus tyrosine kinase inhibitors. Similarities and differences.
    Dassonville O; Bozec A; Fischel JL; Milano G
    Crit Rev Oncol Hematol; 2007 Apr; 62(1):53-61. PubMed ID: 17324578
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparing antibody and small-molecule therapies for cancer.
    Imai K; Takaoka A
    Nat Rev Cancer; 2006 Sep; 6(9):714-27. PubMed ID: 16929325
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The next generation of antibody-drug conjugates comes of age.
    Beck A; Haeuw JF; Wurch T; Goetsch L; Bailly C; Corvaïa N
    Discov Med; 2010 Oct; 10(53):329-39. PubMed ID: 21034674
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [EGF receptor blockade--a new cancer therapy].
    Nexø E; Tørring N; Sørensen BS
    Ugeskr Laeger; 2002 Feb; 164(6):777. PubMed ID: 11851187
    [No Abstract]   [Full Text] [Related]  

  • 16. A new smart way to treat cancer.
    Johns Hopkins Med Lett Health After 50; 2003 Oct; 15(8):1-2, 7. PubMed ID: 14619801
    [No Abstract]   [Full Text] [Related]  

  • 17. [Intensive search for agents that knock out tumor growth].
    Ostman A
    Lakartidningen; 2010 Apr 21-27; 107(16):1066-70. PubMed ID: 20476703
    [No Abstract]   [Full Text] [Related]  

  • 18. Bar the windows but open the door to randomization.
    Ratain MJ
    J Clin Oncol; 2010 Jul; 28(19):3104-6. PubMed ID: 20516430
    [No Abstract]   [Full Text] [Related]  

  • 19. Cripto monoclonal antibodies.
    Hu XF; Xing PX
    Drug News Perspect; 2005 Jun; 18(5):293-303. PubMed ID: 16193101
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A review of EGFR targeted therapy.
    Baselga J
    Clin Adv Hematol Oncol; 2003 Apr; 1(4):218-9. PubMed ID: 16224409
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.